KPC Pharmaceuticals

KPC Pharmaceuticals Dividend Coverage

The Dividend Coverage Ratio of KPC Pharmaceuticals (600422.SS) as of Nov 4, 2026 is 1.46. In the previous year, Dividend Coverage Ratio was 4.36 — a change of -66.49% (lower).

Dividend Coverage

1.46

YoY

-66.49%

Last updated:

Dividend Coverage Ratio of KPC Pharmaceuticals is 2025 1.46 . Dividend Coverage Ratio of KPC Pharmaceuticals was 2024 4.36 . It decreases by -66.49% lower compared to the previous year.

The KPC Pharmaceuticals Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2017
2.36 CNY
Jan 1, 2019
5.98 CNY
Jan 1, 2020
3.00 CNY
Jan 1, 2021
2.92 CNY
Jan 1, 2022
1.96 CNY
Jan 1, 2023
4.37 CNY
Jan 1, 2024
4.36 CNY
Jan 1, 2025
1.46 CNY
The KPC Pharmaceuticals Dividend Coverage history
YEARDividend CoverageYoY
1.46-66.49%
4.36-0.32%
4.37+123.06%
1.96-32.81%
2.92-2.78%
3.00-49.80%
5.98+153.33%
2.36-6.31%
2.52-43.60%
4.47+199.92%
1.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KPC Pharmaceuticals Stock analysis

What does KPC Pharmaceuticals do? KPC Pharmaceuticals, Inc. generates revenue through the research, development, manufacturing, and international marketing of its diverse drug portfolio. The company sells natural herbal medicines, traditional Chinese medicines, and chemical synthetic drugs, including central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines, and anti-inflammatory drugs. Its main customers are healthcare providers, hospitals, and pharmaceutical distributors globally. The firm also produces health products and offers medical services as additional revenue streams. The company's product segments are defined by therapeutic categories such as central nervous system treatments, cardiovascular care, and anti-inflammatory solutions. These products target both domestic and international markets, with a focus on traditional Chinese medicine and natural herbal formulations. Sales are driven by wholesale distribution networks and direct commercial partnerships in the pharmaceutical industry. KPC Pharmaceuticals' revenue model combines product sales from its core drug lines with supplementary health product offerings and medical service provision. The business leverages its manufacturing capabilities in Kunming, Yunnan to serve global markets, with a strong emphasis on traditional Chinese medicine and natural herbal medicine segments. The firm's international marketing efforts support its presence in multiple regions. KPC Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KPC Pharmaceuticals stock

Dividend Coverage Ratio of KPC Pharmaceuticals is 1.46 in 2025.

Dividend Coverage Ratio of KPC Pharmaceuticals changed from 4.36 to 1.46, representing a -66.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio KPC Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's KPC Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — KPC Pharmaceuticals

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — KPC Pharmaceuticals